Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Specialized palliative care in patients with haematological malignancies receiving chimeric antigen receptor T-cell therapy.
Eichenauer DA, Heger JM, Kruschel I, Kutsch N, Gödel P, Garcia Borrega J, Schnetzke U, Böll B, Neumann MA, Gebel C, Pralong A, Borchmann P, Voltz R, Wedding U, Simon ST. Eichenauer DA, et al. Among authors: borchmann p. Br J Haematol. 2024 Mar 24. doi: 10.1111/bjh.19434. Online ahead of print. Br J Haematol. 2024. PMID: 38522848 No abstract available.
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma.
Böll B, Borchmann P, Topp MS, Hänel M, Reiners KS, Engert A, Naumann R. Böll B, et al. Among authors: borchmann p. Br J Haematol. 2010 Feb;148(3):480-2. doi: 10.1111/j.1365-2141.2009.07963.x. Epub 2009 Oct 15. Br J Haematol. 2010. PMID: 19863533 Free article. Clinical Trial. No abstract available.
Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Halbsguth TV, Nogová L, Mueller H, Sieniawski M, Eichenauer DA, Schober T, Nisters-Backes H, Borchmann P, Diehl V, Engert A, Josting A. Halbsguth TV, et al. Among authors: borchmann p. Blood. 2010 Sep 23;116(12):2026-32. doi: 10.1182/blood-2009-11-253211. Epub 2010 Jun 15. Blood. 2010. PMID: 20551376 Free article. Clinical Trial.
Emerging drugs for Hodgkin's lymphoma.
Böll B, Borchmann P, Diehl V. Böll B, et al. Among authors: borchmann p. Expert Opin Emerg Drugs. 2010 Dec;15(4):585-95. doi: 10.1517/14728214.2010.505602. Epub 2010 Jul 15. Expert Opin Emerg Drugs. 2010. PMID: 20629601 Review.
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Eichenauer DA, Fuchs M, Pluetschow A, Klimm B, Halbsguth T, Böll B, von Tresckow B, Nogová L, Borchmann P, Engert A. Eichenauer DA, et al. Among authors: borchmann p. Blood. 2011 Oct 20;118(16):4363-5. doi: 10.1182/blood-2011-06-361055. Epub 2011 Aug 9. Blood. 2011. PMID: 21828141 Free article. Clinical Trial.
247 results